• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • COVID-19
  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • Artificial Intelligence
    • Blockchain
    • Mobile Health
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Collective Health Launches COVID-19 Workplace Solution to Facilitate Safer Workforce Reentry

by Fred Pennic 05/18/2020 Leave a Comment

Collective Health Launches COVID-19 Workplace Solution to Facilitate Safer Workforce Reentry

What You Should Know:

– Collective Health launches COVID-19 workplace solution to help businesses reduce risk and facilitate safe work reentry

– As economic pressure continues to force broader re-openings across the U.S., Collective Go includes a testing ecosystem, occupational health protocol, mobile app, and HIPAA compliant platform.


Collective Health, a San Francisco, CA-based employee healthcare company with an integrated technology solution, today announced the launch of Collective Go, a COVID-19 workplace solution designed to help businesses and their workers reduce risk and navigate safer workforce reentry, with a measured and evidence-based approach. The solution was designed with guidance from in-house epidemiologists and developed by leveraging Collective Health’s existing technology framework and digital tools.

Collective Go has the ability to evolve with the ever-changing landscape of risk reduction options, with the flexibility to broaden beyond its initial offering and expand to support contact tracing, after APIs are widely available, or immunization compliance.


Collective Go Key Components

The key components of Collective Go include: 

Testing ecosystem: Collective Go brings businesses choice in COVID-19 testing types and can support/receive data from any type of test or lab. At launch, Collective Go includes the launch of a network of testing companies including: 

Everlywell: As part of Collective Go, Everlywell will work to bring its diagnostic COVID-19 PCR testing solution to U.S. businesses. Everlywell has helped half a million individuals access quality lab testing for a variety of medical conditions from home. Since the start of the pandemic, Everlywell has supplied hospitals, clinics, nursing homes, and city governments across America with enough COVID-19 testing to help get tens of thousands of frontline healthcare workers and their patients tested for the virus.

Color:  Begin offering an initial testing solution for front-line and essential workers, and which will build on Color’s work with the City of San Francisco and other employers. For this partnership, Color implements the Collective Go protocols, supplies and provisions collection kits, supports onsite and distributed testing logistics, processes samples in their CLIA-certified lab network, and communicates results to patients and public health authorities.

Genalyte: Offering real-time diagnostics with a decentralized lab model, plans to expand the reach of its new rapid COVID-19 serology test to businesses by partnering with Collective Go

Occupational health protocol:  Collective Go is underpinned by a peer-reviewed protocol that takes into account testing frequency, workplace characteristics, local epidemiology trends, and more. The Collective Go protocol will serve as an evidence-based, peer-reviewed, and continuously-updated guideline to help businesses understand and minimize the risk of coronavirus introduction in the workplace. Notably, the protocol received peer review and support from former FDA commissioners including Dr. Scott Gottlieb and Dr. Mark McClellen. 

Mobile application for workers and a HIPAA-compliant platform for companies:

For workers, streamlined, and privacy-oriented app experience with symptom and exposure checking, test status monitoring, and certification of compliance with business workplace testing protocols,

For businesses, a platform with the ability to understand where workers are on their path to compliance with the protocol and their workplace reentry, not worker health details


Collective Go Expansion Plans

The Collective Go ecosystem will continue to expand to include more testing modalities, including at-home and self-administered tests as they receive FDA Emergency Use Authorization and validation. Collective Go is anticipated to begin rolling out in June 2020.

“Frequent, verifiable, and large-scale testing, coupled with continuous risk evaluation and contact tracing is the only way to help Americans get back to some sense of normalcy,” said Ali Diab, Co-founder, and CEO of Collective Health. “Businesses currently don’t have a clear path forward. They need a comprehensive solution, based on the latest science, to enable them to reopen with confidence. Collective Go will deliver high-quality testing options, provide support for workers navigating the testing process, and have the capability to receive and verify data from multiple testing and tracing sources. A comprehensive approach like this is what’s needed for businesses to understand and improve the safety of their workforces.”

Tagged With: Collective Health, Coronavirus (COVID-19), EverlyWell, FDA, HIPAA, hipaa-compliant, model, Public Health, risk, SAN FRANCISCO, workplace

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Most Popular

Survey: Clinician Burnout Is A Public Health Crisis Demanding Urgent Action

17 Execs Share How Health IT Can Address Clinician Burnout, Staffing, & Capacity

Q/A: Dr. Johnson Talks Racial Disparities in Breast Cancer Care

Q/A: Dr. Johnson Talks Racial Disparities in Breast Cancer Care

Northwell Health Extends Contract with Allscripts Sunrise Platform Through 2027

Northwell to Deploy Epic Enterprise EHR Platform Across System

Sanofi Cuts Price of Lantus Insulin by 78% & Caps Out of Pocket Costs at $35 for All Patients

Sanofi Cuts Price of Lantus Insulin by 78% & Caps Out of Pocket Costs at $35 for All Patients

Pfizer Acquires Seagen for $43B to Tackle Cancer

Pfizer Acquires Seagen for $43B to Tackle Cancer

5 Key Trends Driving Purchasing Decisions in Healthcare IT

5 Key Trends Driving Purchasing Decisions in Healthcare IT

Sanofi to Acquire Diabetes Therapy Maker Provention Bio for $2.9B

Sanofi to Acquire Diabetes Therapy Maker Provention Bio for $2.9B

Dr. Arti Masturzo

Q/A: Dr. Masturzo Talks Addressing Food Insecurity with Patients

Transcarent Acquires 98point6 AI-Powered Virtual Care Platform and Care Business

Transcarent Acquires 98point6 AI-Powered Virtual Care Platform and Care Business

Eli Lilly Cuts Insulin Prices by 70%, Caps Patient Costs at $35 Per Month

Eli Lilly Cuts Insulin Prices by 70%, Caps Patient Costs at $35 Per Month

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • 2023 Editorial Calendar
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2023. HIT Consultant Media. All Rights Reserved. Privacy Policy |